The company remains committed to maintain the highest standards of compliance and will work closely with the agency to comprehensively address all the observations
The company is preparing a detailed response to the observations, which will be submitted to the USFDA within the stipulated timelines.
Zydus is the first company to receive final approval and launch Topiramate Extended-Release Capsules, USP 25 mg, 50 mg, and 100 mg in the United States.
Miravo to remain a Canadian controlled and operated company following closing of the transaction
J. B. Chemicals & Pharmaceuticals has informed that the acquisition of the Razel franchise from Glenmark Pharmaceuticals Limited has been successfully completed.
First PARP inhibitor and new hormonal agent combination approved for these patients in Europe
Indira IVF integrates diagnostics services with a special focus on women & child care to increase accessibility for patients
Aster DM Healthcare and Faruk Medical City will jointly provide training and academic support to medical and paramedical staff
The service includes full fertility care benefits, including egg and embryo freezing options to employees
Evaluating Investigational Sitravatinib in combination with Nivolumab for patients with non-squamous non-small cell lung cancer
Subscribe To Our Newsletter & Stay Updated
